VPC-13789
VPC-13789 is a potent, selective, and orally bioavailable antiandrogen, demonstrating promise for castration-resistant prostate cancer (CRPC) research. It inhibits androgen receptor transcriptional activity in LNCaP cells with an IC50 of 0.19 μM. Its profile supports investigation in both in vitro mechanistic studies and in vivo xenograft models for therapeutic development.
Product Specifications
CAS Number
2761146-51-2
Field of Research
Metabolism Research
Smiles
FC1=C2C (C (=CN2) C3=NC4=C (C=C3) C (C (NC (C) C) =O) =CC=C4) =CC (F) =C1F
Molecular Formula
C21H16F3N3O
Molecular Weight
383.37
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Trans-4- (4-Amino-5- (7-Methoxy-1H-Indol-2-Yl) Imidazo[5,1-f][1,2,4]Triazin-7-Yl) Cyclohexanecarboxylic Acid](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
OR1024300-01 100 mg
Trans-4- (4-Amino-5- (7-Methoxy-1H-Indol-2-Yl) Imidazo[5,1-f][1,2,4]Triazin-7-Yl) Cyclohexanecarboxylic Acid
Sign In for Pricing
View Details OR1024300-02 250 mg
Trans-4- (4-Amino-5- (7-Methoxy-1H-Indol-2-Yl) Imidazo[5,1-f][1,2,4]Triazin-7-Yl) Cyclohexanecarboxylic Acid
Sign In for Pricing
View Details 
E7180L 96 Reactions
NEBNext Companion Module for Oxford Nanpore Technlogies Ligation Sequencing
Sign In for Pricing
View Details